摘要
背景:人类接触杀虫剂引起全世界严重的公众健康问题。杀虫剂是一种广泛的异质性化学物质,其中大多数是针对神经系统的。干和扰乱neurometabolism和/或神经传递。虽然是有据可查的人类中毒的急性效应,慢性和长期的影响仍然难以投资castigate严厉批评 目的和方法:我们试图回顾人类接触杀虫剂的急性、慢性、神经发育和神经系统后果的现状。 结果:动物和流行病学研究表明,长期接触杀虫剂的哺乳动物的认知、行为和精神运动改变。帕金森和阿尔茨海默氏症,肌萎缩L侧索硬化,抑郁,已定期与接触杀虫剂有关。临床研究,通过动物实验的支持,证明杀虫剂的毒性影响E在大脑发育期间暴露,发育中的大脑特别容易受到杀虫剂的作用。此外,解毒系统,具有高度的多态性导致杀虫剂毒性效应易感性的个体间变异。 结论:轻度慢性杀虫剂暴露对多种神经系统疾病的发病有重要影响。然而,neurodegene出现的迟发性性疾病和变异的易感性的神经使其难以评估农药暴露的相对贡献。应该保持高度警惕因此应针对可能接触杀虫剂,尤其是在脑发育期。
关键词: 杀虫剂,农药中毒,神经发育毒性、神经毒性、农药。
Current Medicinal Chemistry
Title:Neurotoxicity of Insecticides
Volume: 24 Issue: 27
关键词: 杀虫剂,农药中毒,神经发育毒性、神经毒性、农药。
摘要: Background: Human exposure to insecticides raises serious public health concerns worldwide. Insecticides constitute a wide-ranging heterogeneous group of chemicals, most of which target the nervous system and disrupt neurometabolism and/or neurotransmission. Although the acute effects of insecticide poisoning in humans are well documented, the chronic and long-term effects remain difficult to investigate.
Objectives and Method: We sought to review the present state-of-knowledge of acute, chronic, neurodevelopmental and neurological consequences of human exposure to insecticides.
Results: Animal and epidemiologic studies indicate cognitive, behavioral and psychomotor alterations in mammals chronically exposed to insecticides. Parkinson’s and Alzheimer’s diseases, amyotrophic lateral sclerosis, and depression, have been regularly associated with insecticide exposure. Clinical studies, supported by experiments on animal models, demonstrate the neurotoxic impact of insecticide exposure during the period of cerebral development, the developing brain being particularly vulnerable to the action of insecticides. Moreover, detoxifying systems that are highly polymorph lead to great inter-individual variability in susceptibility to the neurotoxic effects of insecticides.
Conclusion: Studies on mild chronic exposure to insecticides suggest significant involvement in the pathogenesis of multifactorial neurological diseases. However, the tardive appearance of neurodegenerative disorders and the large variability of inter-individual susceptibility to neurotoxicants make it difficult to assess the relative contribution of insecticide exposure. Close vigilance should therefore be exercised with regard to possible exposure to insecticides, particularly during the period of cerebral development.
Export Options
About this article
Cite this article as:
Neurotoxicity of Insecticides, Current Medicinal Chemistry 2017; 24 (27) . https://dx.doi.org/10.2174/0929867324666170526122654
DOI https://dx.doi.org/10.2174/0929867324666170526122654 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Micro Arrays and Biochips: Applications and Potential in Genomics and Proteomics
Current Genomics Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders
Current Pharmaceutical Design Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design
Current Topics in Medicinal Chemistry Shoulder Manifestations of Diabetes Mellitus
Current Diabetes Reviews Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
Current Alzheimer Research Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development
Current Pharmaceutical Design Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases
Current Alzheimer Research Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease
Current Medicinal Chemistry Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair
CNS & Neurological Disorders - Drug Targets Novel Drug Delivery Systems for Releasing Growth Factors to the CNS: Focus on Alzheimer`s and Parkinson`s Diseases
Mini-Reviews in Medicinal Chemistry Editorial [Hot topic: Neuroprotection in ALS: From Pathology to Treatment (Guest Editors: Gabriele Siciliano and Luigi Murri)]
CNS & Neurological Disorders - Drug Targets Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases
Current Pharmaceutical Design Potential Therapeutic Targets for Neurodegenerative Diseases: Lessons Learned from Calorie Restriction
Current Drug Targets Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Other Anti- Inflammatory Agents in the Treatment of Neurodegenerative Disease
Current Alzheimer Research Drusen in the Peripheral Retina of the Alzheimer’s Eye
Current Alzheimer Research Potential Roles of Selenium and Selenoproteins in the Prevention of Alzheimer's Disease
Current Topics in Medicinal Chemistry Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis
Current Psychopharmacology AMPA Receptor Antagonists: Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets